Biologically active quinoline and quinazoline alkaloids part I
XF Shang, SL Morris‐Natschke, YQ Liu… - Medicinal research …, 2018 - Wiley Online Library
Quinoline and quinazoline alkaloids, two important classes of N‐based heterocyclic
compounds, have attracted tremendous attention from researchers worldwide since the 19th …
compounds, have attracted tremendous attention from researchers worldwide since the 19th …
Targeting the protein kinase C family: are we there yet?
HJ Mackay, CJ Twelves - Nature Reviews Cancer, 2007 - nature.com
Protein kinase C (PKC) comprises a family of serine/threonine kinases that are involved in
the transduction of signals for cell proliferation, differentiation, apoptosis and angiogenesis …
the transduction of signals for cell proliferation, differentiation, apoptosis and angiogenesis …
Small-molecule cyclin-dependent kinase modulators
AM Senderowicz - Oncogene, 2003 - nature.com
Aberrations in cell cycle progression occur in the majority of human malignancies. The main
pathway affected is the retinoblastoma (Rb) pathway. The tumor suppressor gene Rb is an …
pathway affected is the retinoblastoma (Rb) pathway. The tumor suppressor gene Rb is an …
Targeting triple negative breast cancer: is p53 the answer?
N Turner, E Moretti, O Siclari, I Migliaccio… - Cancer treatment …, 2013 - Elsevier
Triple negative breast cancers, which are defined by lack of expression of estrogen,
progesterone, or HER2 receptors, represent approximately 15% of all breast cancers …
progesterone, or HER2 receptors, represent approximately 15% of all breast cancers …
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
CX Ma, MJC Ellis, GR Petroni, Z Guo, S Cai… - Breast cancer research …, 2013 - Springer
Mutations in TP53 lead to a defective G1 checkpoint and the dependence on checkpoint
kinase 1 (Chk1) for G2 or S phase arrest in response to DNA damage. In preclinical studies …
kinase 1 (Chk1) for G2 or S phase arrest in response to DNA damage. In preclinical studies …
Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae
JJ Pouliot, CA Robertson, HA Nash - Genes to Cells, 2001 - Wiley Online Library
Background The covalent linkage between DNA and the active site tyrosine of
topoisomerase I can be stabilized by chemotherapeutic agents, adjacent DNA lesions, or …
topoisomerase I can be stabilized by chemotherapeutic agents, adjacent DNA lesions, or …
Protein kinase C: a target for anticancer drugs?
HJ Mackay, CJ Twelves - Endocrine-related cancer, 2003 - erc.bioscientifica.com
Protein kinase C (PKC) is a family of serine/threonine kinases that is involved in the
transduction of signals for cell proliferation and differentiation. The important role of PKC in …
transduction of signals for cell proliferation and differentiation. The important role of PKC in …
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells
Camptothecin (CPT) is a potent DNA Topoisomerase I inhibitor with anti-tumor activity in
hematological and solid tumors. However, it did not reach clinical use because of its poor …
hematological and solid tumors. However, it did not reach clinical use because of its poor …
[HTML][HTML] Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study
Abstract Background: 7-Hydroxystaurosporine (UCN-01) inhibits serine–threonine kinases
including the Ca 2+ and phospholipid-dependent protein kinase C (PKC), CDKs 2, 4, 6, Chk …
including the Ca 2+ and phospholipid-dependent protein kinase C (PKC), CDKs 2, 4, 6, Chk …
The landscape of PDK1 in breast cancer
N Wang, J Fu, Z Li, N Jiang, Y Chen, J Peng - Cancers, 2022 - mdpi.com
Simple Summary Approximately 2,261,419 new cases of breast cancer (BC) and 684,996
BC-related deaths are estimated to occur in 2020 globally. New individualized therapeutic …
BC-related deaths are estimated to occur in 2020 globally. New individualized therapeutic …